FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Federal Register

Blood Cell Separator Controls Info Collection

Federal Register notice: FDA sends to OMB an information collection extension for a Class 2 special controls guidance on blood cell separator devices...

Marketing

OPDP to Study Accelerated Approval Disclosures in DTC Ads

The CDER Office of Prescription Drug Promotion solicits public comment on two proposed studies to examine accelerated approval disclosures on direct-t...

Medical Devices

FDA OKs Expanded Age Indication for Avita Medicals Recell

FDA approves an expanded indication for Avita Medicals Recell thermal burn treatment system.

Medical Devices

Stop Using Innova Covid Tests: FDA

FDA says the public should not use the Innova SARS-CoV-2 antigen rapid qualitative test that has been recalled by the company for potential false posi...

Federal Register

Guide on Patient-reported Outcomes in Cancer Trials

Federal Register notice: FDA makes available a draft guidance entitled Core Patient-Reported Outcomes in Cancer Clinical Trials.

Biologics

FDA Extends J&J Covid Vaccine Storage Time

FDA extends from 3 to 4.5 months the approved storage time for the Johnson & Johnson Covid vaccine.

FDA General

Woodcock Updates Senate on Budget Request

Acting FDA commissioner Janet Woodcock describes FDAs current priorities at a Senate appropriations hearing on budget priorities, which includes data ...

Federal Register

Info Collection Extension for Drug GMPs

Federal Register notice: FDA sends to OMB an information collection extension on GMPs for finished pharmaceuticals and active pharmaceutical ingredien...

Federal Register

Medical Imaging Drugs Panel Renewed for 2 Years

Federal Register notice: FDA renews its Medical Imaging Drugs Advisory Committee for an additional two years.

Human Drugs

Cancer Trial Patient-Reported Outcomes Draft Guidance

FDA issues a draft guidance with recommendations for sponsor collection of a core set of patient-reported clinical outcomes in cancer clinical trials.